Back to Search
DAVID KADMON, M.D.
M.D.
Rheumatology Physician
NPI: 1912946658Individual
Specialties, Licenses & Credentials
Rheumatology PhysicianPrimary
Internal Medicine — Rheumatology
Code: 207RR0500X
MD09598(RI)
Specialist
Specialist
Code: 174400000X
MD109667(RI)
Research & Publications (20)
The role of caveolin-1 in prostate cancer: clinical implications.
PMID 19581923·Prostate Cancer Prostatic Dis·2010
6-review
Therapeutic effects of gelatin matrix-embedded IL-12 gene-modified macrophages in a mouse model of residual prostate cancer.
PMID 19104507·Prostate Cancer Prostatic Dis·2009
7-preclinical
Cancer-related axonogenesis and neurogenesis in prostate cancer.
PMID 19047084·Clin Cancer Res·2008
7-preclinical
Tumor cell-secreted caveolin-1 has proangiogenic activities in prostate cancer.
PMID 18245473·Cancer Res·2008
7-preclinical
Bortezomib-mediated inhibition of steroid receptor coactivator-3 degradation leads to activated Akt.
PMID 19010869·Clin Cancer Res·2008
3-trial
Reprint of: Stromogenic prostatic carcinoma pattern (carcinomas with reactive stromal grade 3) in needle biopsies predicts biochemical recurrence-free survival in patients after radical prostatectomy.
PMID 18206496·Hum Pathol·2008
8-other
Neoadjuvant therapy followed by prostatectomy for clinically localized prostate cancer.
PMID 17941029·Cancer·2007
6-review
Correlative evidence that prostate cancer cell-derived caveolin-1 mediates angiogenesis.
PMID 17707459·Hum Pathol·2007
8-other
Stromogenic prostatic carcinoma pattern (carcinomas with reactive stromal grade 3) in needle biopsies predicts biochemical recurrence-free survival in patients after radical prostatectomy.
PMID 17868773·Hum Pathol·2007
8-other
IL-12 gene-modified bone marrow cell therapy suppresses the development of experimental metastatic prostate cancer.
PMID 17627292·Cancer Gene Ther·2007
7-preclinical
Preliminary report of the effect of high-dose adjuvant intensity modulated radiation therapy on the sural nerve graft for cavernosal nerve sacrifice after radical prostatectomy.
PMID 17762440·Am J Clin Oncol·2007
8-other
Long-term benefits of elective radiotherapy after prostatectomy for patients with positive surgical margins.
PMID 16697811·J Urol·2006
8-other
Preoperative serum caveolin-1 as a prognostic marker for recurrence in a radical prostatectomy cohort.
PMID 16914574·Clin Cancer Res·2006
8-other
Biological response determinants in HSV-tk + ganciclovir gene therapy for prostate cancer.
PMID 16480930·Mol Ther·2006
3-trial
CDC4 gene expression as potential biomarker for targeted therapy in prostate cancer.
PMID 16357515·Cancer Biol Ther·2006
8-other
Expanding the therapeutic index of radiation therapy by combining in situ gene therapy in the treatment of prostate cancer.
PMID 16417399·Technol Cancer Res Treat·2006
6-review
The emerging role of the PI3-K-Akt pathway in prostate cancer progression.
PMID 15724144·Prostate Cancer Prostatic Dis·2005
6-review
The effect of statins on serum prostate specific antigen levels in a cohort of airline pilots: a preliminary report.
PMID 15879782·J Urol·2005
8-other
Virus specific immune responses after human neoadjuvant adenovirus-mediated suicide gene therapy for prostate cancer.
PMID 15967266·Eur Urol·2005
3-trial
Reliability of remembered International Index of Erectile Function domain scores in men with localized prostate cancer.
PMID 15667878·Urology·2005
4-observational
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 132 OLD RIVER RD, SUITE B-2
LINCOLN, RI 02865 - Phone
- (401) 333-2784
Quick Facts
- NPI
- 1912946658
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 2
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile